Propofol does not modify the hemodynamic status of children with intracardiac shunts undergoing cardiac

D Gozal1, A J Rein, A Nir

  • 1Department of Anesthesiology and Critical Care Medicine, Hadassah University Hospital and the Hebrew University School of Medicine, Post Office Box 12000, Jerusalem 91120, Israel. gozaly@mdz.huji.ac.il

Pediatric Cardiology
|March 15, 2002
PubMed

Insights

Propofol sedation is safe for pediatric cardiac catheterization. This study found that propofol did not worsen intracardiac shunts, making it an adequate option for these procedures.

Area of Science:

  • Pediatric Cardiology
  • Anesthesiology
  • Cardiovascular Physiology

Background:

  • Cardiac catheterization requires immobility and cardiovascular stability in pediatric patients.
  • Sedation must allow spontaneous ventilation without supplemental oxygen.
  • Propofol is used for stable pediatric patients with congenital heart disease, but hypotension is a concern.

Purpose of the Study:

  • To evaluate the effects of propofol on systemic and pulmonic circulations in pediatric patients undergoing cardiac catheterization.
  • To assess the impact of propofol-induced hypotension on intracardiac shunts.

Main Methods:

  • Fifteen pediatric patients (18 months to 9 years) received fentanyl and titrated propofol for sedation.
  • Hemodynamic data, including pressures and saturations, were recorded during propofol infusion and after discontinuation.
  • Pulmonary to systemic blood flow ratio (Qp/Qs) was calculated to assess shunt extent.

Main Results:

  • Systemic pressures were lower during propofol infusion compared to post-discontinuation.
  • Despite lower pressures, the extent of intracardiac shunts remained unchanged.
  • Propofol facilitated immobility and spontaneous ventilation without supplemental oxygen.

Conclusions:

  • Propofol is an adequate sedative agent for pediatric cardiac catheterization.
  • It can be safely used in patients with intracardiac shunts.
  • The potential for mild hypotension does not significantly alter shunt physiology.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...